Corrigendum to “Novel approach for infrared spectroscopic quantitation of azithromycin in commercial tablets employing paracetamol as matrix modifier” [Heliyon 9 (3) (March 2023) Article e14647]

Detalles Bibliográficos
Autores principales: Doan, Cao Son, Bui, Van Trung, Tong, Thi Thanh Vuong, Le, Dinh Chi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256841/
https://www.ncbi.nlm.nih.gov/pubmed/37305458
http://dx.doi.org/10.1016/j.heliyon.2023.e15729
_version_ 1785057192221605888
author Doan, Cao Son
Bui, Van Trung
Tong, Thi Thanh Vuong
Le, Dinh Chi
author_facet Doan, Cao Son
Bui, Van Trung
Tong, Thi Thanh Vuong
Le, Dinh Chi
author_sort Doan, Cao Son
collection PubMed
description
format Online
Article
Text
id pubmed-10256841
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-102568412023-06-11 Corrigendum to “Novel approach for infrared spectroscopic quantitation of azithromycin in commercial tablets employing paracetamol as matrix modifier” [Heliyon 9 (3) (March 2023) Article e14647] Doan, Cao Son Bui, Van Trung Tong, Thi Thanh Vuong Le, Dinh Chi Heliyon Corrigendum Elsevier 2023-04-27 /pmc/articles/PMC10256841/ /pubmed/37305458 http://dx.doi.org/10.1016/j.heliyon.2023.e15729 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Corrigendum
Doan, Cao Son
Bui, Van Trung
Tong, Thi Thanh Vuong
Le, Dinh Chi
Corrigendum to “Novel approach for infrared spectroscopic quantitation of azithromycin in commercial tablets employing paracetamol as matrix modifier” [Heliyon 9 (3) (March 2023) Article e14647]
title Corrigendum to “Novel approach for infrared spectroscopic quantitation of azithromycin in commercial tablets employing paracetamol as matrix modifier” [Heliyon 9 (3) (March 2023) Article e14647]
title_full Corrigendum to “Novel approach for infrared spectroscopic quantitation of azithromycin in commercial tablets employing paracetamol as matrix modifier” [Heliyon 9 (3) (March 2023) Article e14647]
title_fullStr Corrigendum to “Novel approach for infrared spectroscopic quantitation of azithromycin in commercial tablets employing paracetamol as matrix modifier” [Heliyon 9 (3) (March 2023) Article e14647]
title_full_unstemmed Corrigendum to “Novel approach for infrared spectroscopic quantitation of azithromycin in commercial tablets employing paracetamol as matrix modifier” [Heliyon 9 (3) (March 2023) Article e14647]
title_short Corrigendum to “Novel approach for infrared spectroscopic quantitation of azithromycin in commercial tablets employing paracetamol as matrix modifier” [Heliyon 9 (3) (March 2023) Article e14647]
title_sort corrigendum to “novel approach for infrared spectroscopic quantitation of azithromycin in commercial tablets employing paracetamol as matrix modifier” [heliyon 9 (3) (march 2023) article e14647]
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256841/
https://www.ncbi.nlm.nih.gov/pubmed/37305458
http://dx.doi.org/10.1016/j.heliyon.2023.e15729
work_keys_str_mv AT doancaoson corrigendumtonovelapproachforinfraredspectroscopicquantitationofazithromycinincommercialtabletsemployingparacetamolasmatrixmodifierheliyon93march2023articlee14647
AT buivantrung corrigendumtonovelapproachforinfraredspectroscopicquantitationofazithromycinincommercialtabletsemployingparacetamolasmatrixmodifierheliyon93march2023articlee14647
AT tongthithanhvuong corrigendumtonovelapproachforinfraredspectroscopicquantitationofazithromycinincommercialtabletsemployingparacetamolasmatrixmodifierheliyon93march2023articlee14647
AT ledinhchi corrigendumtonovelapproachforinfraredspectroscopicquantitationofazithromycinincommercialtabletsemployingparacetamolasmatrixmodifierheliyon93march2023articlee14647

Ejemplares similares